Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute vision loss in older people, and there is no effective therapy. The effect of the systemic or local application of steroids for NAION patients remains controversial. Oroxylin A (OA) (5,7-dihydroxy-6-methoxyflav...
Saved in:
Main Authors: | Jia-Ying Chien (Author), Shu-Fang Lin (Author), Yu-Yau Chou (Author), Chi-Ying F. Huang (Author), Shun-Ping Huang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Two Nrf2 Activators, Bardoxolone Methyl and Omaveloxolone, on Retinal Ganglion Cell Survival during Ischemic Optic Neuropathy
by: Jia-Ying Chien, et al.
Published: (2021) -
Tetrandrine protects mouse retinal ganglion cells from ischemic injury
by: Li WY, et al.
Published: (2014) -
Vitamin B3 Provides Neuroprotection via Antioxidative Stress in a Rat Model of Anterior Ischemic Optic Neuropathy
by: Tu-Wen Chen, et al.
Published: (2022) -
Anterior ischemic optic neuropathy in a patient with erectile dysfunction: Tadalafil as an offending medication
by: Alireza Dehghani, et al.
Published: (2018) -
Regional and central hemodynamics in ischemic optic neuropathy
by: N.I. Khramenko, et al.
Published: (2018)